B lymphocyte maturation in Wegener's qranulomatosis: A comparative analysis of VH genes from endonasal lesions

Annals of the Rheumatic Diseases

Volumn 65, Issue 7, 2006, Pages 859-864

  Voswinkle, Jan ^a,b   Mueller, A ^b   Kraemer, J A ^b   Lamprecht, P ^b   Herlyn, K ^b   Holl Ulrich, K ^c   Feller, A C ^c   Pitann, S ^b   Gause, A ^b   Gross, W L ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BINDING SITE; CELL INFILTRATION; CELL MATURATION; CELL SELECTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DNA SEQUENCE; GENE MUTATION; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VH GENE; IMMUNOHISTOCHEMISTRY; MALE; MEMORY CELL; MOLECULAR CLONING; NASAL BIOPSY; NOSE DISEASE; PLASMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRUCTURAL HOMOLOGY; WEGENER GRANULOMATOSIS;

AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CLONING, MOLECULAR; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYELOBLASTIN; NASAL MUCOSA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SERINE ENDOPEPTIDASES; STATISTICS, NONPARAMETRIC; WEGENER GRANULOMATOSIS;

EID: 33745697938     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.044909     Document Type: Article

References (30)

1. Lang KS, Recher M, Junt T, Navarini AA, Harris NL, Freigang S, et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 2005;11:138-45.
2. Zinkernagel RM, Hengartner H. Regulation of the immune response by antigen. Science 2001;293:251-3.
3. Luedemann J, Utecht B, Gross WL. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990;171:357-62.
4. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
5. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998;53:743-53.
6. Choi HK, Lamprecht P, Miles JL, Gross WL, Merkel PA. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum 2000;43:226-31.
7. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-19.
8. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002;110:955-63.
9. Pfister H, Ollert M, Froehlich LF, Quintanilla-Martinez L, Colby TV, Specks U, et al. Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 2004;104:1411-18.
10. Jayne D. Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 2001;13:48-55.
11. Bacon P. The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med 2005;352:330-2.
12. Stegeman CA, Cohen Tervaert JW, De Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (Co-Trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996;335:16-20.
13. Keogh KA, Wylam ME, Stone JH, Specks U. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody- associated vasculitis. Arthritis Rheum 2005;52:262-8.
14. Mueller A, Trabandt A, Gloeckner-Hofmann K, Seitzer U, Schoenermarck U, Csernok E, et al. Localized Wegener's granulomatosis: predominance of CD26 and IFN-gamma expression. J Pathol 2000;192:113-20.
15. Mueller A, Holl-Ullrich K, Feller AC, Gross WL, Lamprecht P. Immune phenomena in localized and generalized Wegener's granulomatosis. Clin Exp Rheumatol 2003;21:49-54.
16. Brezinschek HP, Brezinschek RI, Lipsky PE. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 1995;155:190-202.
17. Braun MG, Csernok E, Gross WL, Mueller-Hermelink HK. Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues. Am J Pathol 1991;139:831-8.
18. Voswinkel J, Weisgerber K, Pfreundschuh M, Cause A. The B lymphocyte in rheumatoid arthritis: recirculation of B lymphocytes between different joints and blood. Autoimmunity 1999;31:25-34.
19. de Wildt RM, Hoet RM, van Venrooij WJ, Tomlinson IM, Winter G. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol 1999;285:895-901.
20. Mebius RE. Organogenesis of lymphoid tissues. Nat Rev Immunol 2003;3:292-303.
21. Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A, Rajewsky K, et al. Somatic hypermutation in normal and transformed human B cells. Immunol Rev 1998;162:261-80.
22. Voswinkel J, Trümper L, Carbon G, Hopf T, Pfreundschuh M, Gause A. Evidence for a selected humoral immune response encoded by VH4 family genes in the synovial membrane of a patient with rheumatoid arthritis. Clin Exp Immunol 1996;106:5-12.
23. Voswinkel J, Gause A. From immunoglobulin gene fingerprinting to motif-specific hybridization: advances in the analysis of B lymphoid clonality in rheumatic diseases. Arthritis Res 2002;4:1-4.
24. Pascual V, Capra JD. VH4-21, a human VH gene segment overrepresented in the autoimmune repertoire. Arthritis Rheum 1992;35:11-18.
25. Sibilia J, Benlagha K, Vanhille P, Ronco P, Brauet JC, Mariette X. Structural analysis of human antibodies to proteinase 3 from patients with Wegener granulomatosis. J Immunol 1997;159:712-19.
26. Williams RC, Staud R, Malone CC, Payabyab J, Byres L, Underwood D. Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis. J Immunol 1994;152:4722-37.
27. Peen E, Williams RC. What you should know about PR3-ANCA. Structural aspects of antibodies to proteinase 3 (PR3). Arthritis Res 2000;2:255-9.
28. Domiati-Saad R, Attrep JF, Brezinschek HP, Cherrie AH, Karp DR, Lipsky PE. Staphylococcal enterotoxin D functions as a human B cell superantigen by rescuing VH4-expressing B cells from apoptosis. J Immunol 1996;156:3608-20.
29. Hakoda M, Kamatani N, Hayashimoto-Kurumada S, Silverman GJ, Yamanaka H, Terai C, et al. Differential binding avidities of human IgM for staphylococcal protein A derived from specific germ-line VH3 gene usage. J Immunol 1996;157:2976-81.
30. Popa ER, Stegeman CA, Kallenberg CGM, Cohen Tervaert JW. Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res 2002;4:77-9.